Notes / Company

Remus Pharmaceuticals Ltd.

REMUS ISIN INE0O5T01011 Trading

Fundamentals

Market cap: ₹896 cr
P/E: 36.28×
ROE: 11.36%
Debt / equity: 0.08
Div yield: 0.13%
52-week range: 580.00 — 1069.97

Research on Tijori Finance

The timeline — 1 note on Remus Pharmaceuticals Ltd.

May 2026

21 May 26 · 15:16 IST Brief

Brief · Concalls

Remus Pharma bets on B2C and GLP-1 after 38% revenue jump

FY26 growth was strong, but the real story is the planned shift toward higher-margin consumer revenue, with B2C targeting 30% of sales.

Verify on exchange NSE filings for REMUS Tijori Finance company page